Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Video
▼
News
▼
Meeting Reports
Slides
▼
About
BET Inhibition
▼
CV Inflammation
▼
Diabetes & CVD
▼
ESC 2017
▼
Lp(a)
▼
PCSK9
▼
PCSK9 expert opinions
▼
BP-lowering medication should not be used in normotensive primary prevention population at intermediate CV risk
May 10, 2016 - ACC 2016, Chicago, IL, USA - Eva Lonn (Hamilton, ONT, Canada)
